By 2009, there were no generics and brand-name albuterol inhaler prices had nearly tripled, with one brand, ProAir, costing patients more than $40 out of pocket for a medicine they had to refill ...
Dry powder inhalers can be substituted for metered-dose types by a majority of patients but can also come at a higher price ... GSK’s metered-dose Ventolin inhaler, prescribed to around 35 ...
Oppenheimer raised the firm’s price target on Walmart to $90 from $81 and keeps an Outperform rating on the shares. The firm believes Walmart remains well positioned to deliver the company’s ...
Walmart's U.S. chief vowed to do "everything" he can to keep prices low, as the nation grapples with recent disasters and inflation amid a quickly approaching holiday shopping season. "Before the ...
Walmart, for example, is having a major Holiday Deals sale this week that features price rollbacks in every department in the store. Not only are the deals worth checking out — some are even ...
an opportunity to raise their prices. AstraZeneca and GlaxoSmithKline produce some of the most widely used inhalers in the United States, including Symbicort and Ventolin. They plan to seek ...
Honeywell Solstice® Air can cut metered dose inhaler greenhouse gas emissions of up to 99.9% versus current propellants 1 By using Honeywell Solstice ® Air HFO-1234ze technology, a low global warming ...
A price war occurs when two or more rival companies lower the prices of their products or services with the goal of stealing customers from their competitors or gaining market share. Price wars ...
In the phase 3b BATURA trial, Airsupra—a pressurized metered-dose inhaler containing albuterol and budesonide—significantly reduced the risk of severe exacerbation when used as an as-needed ...
So that means the newer, better version is available at a cheaper price. More Deals on Gaming Headsets EPOS H6Pro Closed Acoustic Gaming Over-Ear Headset (Black) for $150.36 (List Price $179.00) ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...